Physician profile
Joseph Hill
NPI 1508354572
$1,952.95
in general payments reported to CMS, 2019-2025
16 companies · $726 in 2025
The $726 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $582 · 2024: $645 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $654.62 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Boston Scientific Corporation | $236.63 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $190.32 | 2023-2024 | Belbuca, Xtampza |
| Globus Medical, INC. | $166.83 | 2025 | Senza |
| Abbott Laboratories | $112.49 | 2023 | Proclaim |
| Averitas Pharma INC. | $108.33 | 2024-2025 | Qutenza |
| Nevro Corp. | $90.15 | 2024 | Senza |
| Abbvie INC. | $89.54 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $83.05 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $77.11 | 2023-2024 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $42.35 | 2024 | Dysport |
| Vertex Pharmaceuticals Incorporated | $33.17 | 2025 | |
| Spr Therapeutics, INC | $23.20 | 2024 | Sprint Pns System |
| Coloplast Corp | $17.39 | 2025 | |
| Kyowa Kirin, INC. | $14.15 | 2024 | Crysvita |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.